Publications
- Determination of CD34+ cells in bone marrow, peripheral blood, umbilical cord blood, and apheresis products using flow cytometry (ISHAGE) [Gate: CD34 ISHAGE]Publication without faculty affiliation
- NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on MRD-based protocol2023 | Second Faculty of Medicine
- Blast clearance after one week of corticosteroids correlates with outcome and genetics but does not justify adding a residual disease time point in acute lymphoblastic leukemia treatment2021 | Second Faculty of Medicine
- CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage2014 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine, Central Library of Charles University
- CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage2014 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Minimal residual disease in peripheral blood at day 15 identifies a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with superior prognosis2011 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Minimal residual disease in peripheral blood at day 15 identifies a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with superior prognosis2011 | Second Faculty of Medicine
- Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?2008 | Second Faculty of Medicine
- TEL/AML1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALL2005 | Second Faculty of Medicine
- Determination of lymphocyte subpopulations (CD3+, CD4+, CD8+, CD19+, CD16,56+) in peripheral blood using flow cytometry [Gate: lymphocytes]Publication without faculty affiliation
Loading network view...